Ranitidine

Chemical formula: C₁₃H₂₂N₄O₃S  Molecular mass: 314.4 g/mol  PubChem compound: 3001055

Therapeutic indications

Ranitidine is indicated for:

Duodenal ulcer, benign gastric ulcer

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Duodenal ulcer disease
Gastric ulcer

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Zollinger-Ellison syndrome

Population group: only adults (18 years old or older)

Zollinger-Ellison syndrome

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastroesophageal reflux disease

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Gastroesophageal reflux disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ulcers following NSAID therapy or associated with continued NSAIDs

Population group: only adults (18 years old or older)

Drug induced gastric ulcer

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Duodenal ulcers associated with Helicobacter pylori infection

Population group: only adults (18 years old or older)

Duodenal ulcer caused by Helicobacter pylori

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastroesophageal reflux disease

Population group: only adults (18 years old or older)

Gastroesophageal reflux disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chronic episodic dyspepsia

Population group: only adults (18 years old or older)

Indigestion

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of acid aspiration (Mendelson's) syndrome

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Aspiration pneumonitis due to and following anaesthesia during labour and delivery

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastroesophageal reflux disease with esophagitis

Population group: only adults (18 years old or older)

Reflux esophagitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Duodenal ulcer, benign gastric ulcer

Population group: only children (1 year - 12 years old)

at least one of
Duodenal ulcer disease
Gastric ulcer

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2016: ZANTAC Tablets
Summary of Product Characteristics (SPC) 2015: ZANTAC Injection (Aqueous solution)
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈